22 Jun 2017

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

A review of the Drug Master Files (DMFs) submitted to the United States Food and Drug Administration (FDA) from October 2016 to March 2017 (the fourth quarter of 2016 and the first quarter of 2017) indicates an extremely robust ph...

Radio Compass

PharmaCompass.com

India leads DMF submissions to the FDA during Q4 of 2016 and Q1 of 2017

22 Jun 2017

Investors up ante against Mylan board; More Ipca products banned from the US

This week, Phispers looks at fresh troubles brewing at Mylan, as rebel investors intensify their demand for remaking the board, and a low-cost rival for EpiPen gets FDA nod. Meanwhile, BMS sold off its API plant in Ireland to Sout...

Radio Compass

PharmaCompass.com

Investors up ante against Mylan board; More Ipca products banned from the US

15 Jun 2017

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

This week in Phispers, we bring you news on J&J’s Invokana, a drug that reduces heart risk while increasing the risk of amputation of toes. There is news from Google, which is tying up with India’s Aravind Eye...

Radio Compass

PharmaCompass.com

J&J’s diabetes drug reduces heart risk at the cost of toes; Google’s AI eye doctor initiative

Top BLOG & ANALYSIS

Copyright © 2017 LePro PharmaCompass OPC Private Limited, All rights reserved.